Literature DB >> 236258

Defects in cell-mediated immunity during growth of a syngeneic simian virus-induced tumor.

S B Howell, J H Dean, L W Law.   

Abstract

Four assays of tumor-specific cell-mediated immunity were compared during growth of a syngeneic Simian-virus-40-induced tumor, mKSA. Major differences were found in immunity detected by the tumor neutralization test (the Winn test), direct tumor challenge, the microcytotoxicity assay and the -51chromium-release lymphocytotoxicity assay. Progressive growth of the neoplasm followed by loss of immunity (the eclipse phenomenon) was documented with the Winn test. It was established that this eclipse phenomenon represented a lesion in the T-cell system of tumor-bearing hosts. This lesion was found to be specific and unrelated to anatomic tumor location. The ability to produce graft-versus-host reactions, and the ability to respond to mitogens, were found to be generally intact in tumor-bearing animals. Cells capable of recognizing mKSA tumor antigens and reconstituting an immune response following surgical removal of tumor or upon transfer to normal mice were found in the spleens of mice bearing advanced tumors. No suppressor cells that might account for the eclipse phenomenon could be demonstrated. Tumor-bearer serum did not block neutralizing activity of immune spleen cells in the Winn test, and immune cells were capable of neutralizing tumor even in tumor-bearing hosts. The possibility that the lesion is intrinsic to T-cell precursors of effector cells is discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 236258     DOI: 10.1002/ijc.2910150118

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

1.  Different responses of lymphoid cells from tumor-bearing as compared to tumor-immunized mice when sensitized to tumor specific antigens in vitro.

Authors:  M A Kall; I Hellström; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

2.  Local microwave hyperthermia (43 degrees C) and stimulation of the macrophage and T-lymphocyte systems in treatment of Guerin epithelioma in rats.

Authors:  M Janiak; W Hryniewicz; J Jeljaszewicz; G Pulverer
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1978-01-26

Review 3.  Immunopathology of polyoma-induced tumors.

Authors:  M Vandeputte
Journal:  Springer Semin Immunopathol       Date:  1982

4.  Cell-mediated immune response of patients with meningiomas defined in vitro by a [3H]proline microcytotoxicity test.

Authors:  H W Pees; B Seidel
Journal:  Clin Exp Immunol       Date:  1976-05       Impact factor: 4.330

5.  Cell-mediated immune reaction against BK virus-transformed cells.

Authors:  R Mäntyjärvi; H Karjalainen; M Laaksonen
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

6.  Temporal transcriptome changes induced by MDV in Marek's disease-resistant and -susceptible inbred chickens.

Authors:  Ying Yu; Juan Luo; Apratim Mitra; Shuang Chang; Fei Tian; Huanmin Zhang; Ping Yuan; Huaijun Zhou; Jiuzhou Song
Journal:  BMC Genomics       Date:  2011-10-12       Impact factor: 3.969

7.  Regression and inhibition of sarcoma growth by interference with a radiosensitive T-cell population.

Authors:  K E Hellström; I Hellström; J A Kant; J D Tamerius
Journal:  J Exp Med       Date:  1978-09-01       Impact factor: 14.307

8.  Significance of arming, potentiating and blocking factors as correlates the tumour-host interaction in the hamster SV40 system.

Authors:  M H Goldrosen; P B Dent
Journal:  Br J Cancer       Date:  1975-12       Impact factor: 7.640

9.  Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells.

Authors:  Mary Jo Turk; José A Guevara-Patiño; Gabrielle A Rizzuto; Manuel E Engelhorn; Shimon Sakaguchi; Alan N Houghton
Journal:  J Exp Med       Date:  2004-09-20       Impact factor: 14.307

10.  A serum-mediated mechanism for concomitant resistance shared by immunogenic and non-immunogenic murine tumours.

Authors:  M Franco; O D Bustuoabad; P D di Gianni; A Goldman; C D Pasqualini; R A Ruggiero
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.